Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 11 to 14 amino acid residues in defined sequence
Patent
1995-02-01
1998-06-16
Davenport, Avis M.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
11 to 14 amino acid residues in defined sequence
514 14, 514 15, A61K 3800, C07K 500, C07K 700
Patent
active
057672342
ABSTRACT:
Peptides that bind to the interleukin-1 type I receptor (IL-1RtI) can be used to assay the amount of IL-1R, or an IL-1R agonist or antagonist, in a sample and comprise a sequence of amino acids selected from the group consisting of (1) WXXXGZ.sub.1 W (SEQ ID NO: 2) where Z.sub.1 is L, I, A, or Q; (2) XXQZ.sub.5 YZ.sub.6 XX where (SEQ ID NO: 1) Z.sub.5 is P or Aze where Aze is azetidine; and Z.sub.6 is S, A, V, or L; and (3) Z.sub.23 NZ.sub.24 SZ.sub.25 Z.sub.26 Z.sub.27 Z.sub.28 Z.sub.29 Z.sub.30 L (SEQ ID NO: 313) where Z.sub.23 is D or Y; Z.sub.24 is D or S; Z.sub.25 is S or W; Z.sub.26 is S or Y; Z.sub.27 is D or V; Z.sub.28 is S or W; Z.sub.29 is F or L; and Z.sub.30 is D or L; and where each amino acid is indicated by standard one letter abbreviation; and each X can be selected from any one of the 20 genetically coded L-amino acids or the stereoisomeric D-amino acids.
REFERENCES:
patent: 4968607 (1990-11-01), Dower et al.
patent: 5039790 (1991-08-01), Adams et al.
patent: 5075222 (1991-12-01), Hannum et al.
patent: 5075288 (1991-12-01), Krueger et al.
patent: 5077219 (1991-12-01), Auron et al.
Bender et al., "Chapter 20: Pharmacological modulation of interleukin-1," Ann. Rep. Med. Chem. 25:185-191 (1989).
Cwirla et al., "Peptides on phage: A vast library of peptides for identifying ligands," Proc. Natl. Acad. Sci. USA 87:6378-6382 (1990).
Dinarello, "Interleukin-1 and interleukin-1 antagonism," Blood 77 (8):1627-1652 (1991).
Dower et al., "The interleukin-1 receptor," Immunol. Today 8 (2):46-51 (1987).
Dower et al., "Human cytokine receptors,"0 J. Clin. Immunol. 10 (6) :289-299 (1990).
Evans et al., "Mapping receptor binding sites in interleukin (IL)-l receptor antagonist and IL-1.beta. by site-directed mutagenesis," J. Biol. Chem. 270(19) :11477-11483 (May 12, 1995).
Fodor et al., "Light-directed, spatially addressable parallel chemical synthesis,"0 Science 251:767-773 (Feb. 15, 1991).
Hannum et al., "Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor," Nature 343:336-340 (1990).
Labriola-Tompkins et al., "Identification of the discontinuous binding site in human interleukin-1.beta. for the type I interleukin 1 receptor," Proc. Natl. Acad. Sci. USA 88:11182-11186 (1991).
Larrick, "Native interleukin 1 inhibitors," Immunol. Today 10(2):61-66 (1989).
McMahan et al., "A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types," EMBO J. 10(10) :2821-2832 (1991)
Baldwin David
Barrett Ronald W.
Jacobs Jeff W.
Yanofsky Stephen D.
Affymax Technologies N.V.
Davenport Avis M.
Murphy Matthew B.
Stevens Lauren L.
LandOfFree
Peptides and compounds that bind to the IL-1 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides and compounds that bind to the IL-1 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and compounds that bind to the IL-1 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726962